Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lower blood pressure goals for cardiovascular and renal risk reduction: are they defensible?

Literature DB >> 19583629

Lower blood pressure goals for cardiovascular and renal risk reduction: are they defensible?

Rigas Kalaitzidis, George L Bakris.

Abstract

Entities: Chemical

Mesh：

Year: 2009 PMID： 19583629 PMCID： PMC8673160 DOI： 10.1111/j.1751-7176.2009.00143.x

Source DB: PubMed Journal: J Clin Hypertens (Greenwich) ISSN： 1524-6175 Impact factor: 3.738

× No keyword cloud information.

13 in total

1. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease.

Authors:
Journal: Am J Kidney Dis Date: 2004-05 Impact factor: 8.860

2. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors: Giuseppe Mancia; Guy De Backer; Anna Dominiczak; Renata Cifkova; Robert Fagard; Giuseppe Germano; Guido Grassi; Anthony M Heagerty; Sverre E Kjeldsen; Stephane Laurent; Krzysztof Narkiewicz; Luis Ruilope; Andrzej Rynkiewicz; Roland E Schmieder; Harry A J Struijker Boudier; Alberto Zanchetti; Alec Vahanian; John Camm; Raffaele De Caterina; Veronica Dean; Kenneth Dickstein; Gerasimos Filippatos; Christian Funck-Brentano; Irene Hellemans; Steen Dalby Kristensen; Keith McGregor; Udo Sechtem; Sigmund Silber; Michal Tendera; Petr Widimsky; José Luis Zamorano; Serap Erdine; Wolfgang Kiowski; Enrico Agabiti-Rosei; Ettore Ambrosioni; Lars H Lindholm; Margus Viigimaa; Stamatis Adamopoulos; Enrico Agabiti-Rosei; Ettore Ambrosioni; Vicente Bertomeu; Denis Clement; Serap Erdine; Csaba Farsang; Dan Gaita; Gregory Lip; Jean-Michel Mallion; Athanasios J Manolis; Peter M Nilsson; Eoin O'Brien; Piotr Ponikowski; Josep Redon; Frank Ruschitzka; Juan Tamargo; Pieter van Zwieten; Bernard Waeber; Bryan Williams
Journal: J Hypertens Date: 2007-06 Impact factor: 4.844

3. The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study.

Authors: Mark J Sarnak; Tom Greene; Xuelei Wang; Gerald Beck; John W Kusek; Allan J Collins; Andrew S Levey
Journal: Ann Intern Med Date: 2005-03-01 Impact factor: 25.391

4. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

Authors:
Journal: BMJ Date: 1998-09-12

5. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal: Hypertension Date: 2003-12-01 Impact factor: 10.190

6. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis.

Authors: Tazeen H Jafar; Paul C Stark; Christopher H Schmid; Marcia Landa; Giuseppe Maschio; Paul E de Jong; Dick de Zeeuw; Shahnaz Shahinfar; Robert Toto; Andrew S Levey
Journal: Ann Intern Med Date: 2003-08-19 Impact factor: 25.391

7. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.

Authors: Peter Gaede; Pernille Vedel; Nicolai Larsen; Gunnar V H Jensen; Hans-Henrik Parving; Oluf Pedersen
Journal: N Engl J Med Date: 2003-01-30 Impact factor: 91.245

8. Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans.

Authors: Lawrence J Appel; Jackson T Wright; Tom Greene; John W Kusek; Julia B Lewis; Xuelei Wang; Michael S Lipkowitz; Keith C Norris; George L Bakris; Mahboob Rahman; Gabriel Contreras; Stephen G Rostand; Joel D Kopple; Francis B Gabbai; Gerald I Schulman; Jennifer J Gassman; Jeanne Charleston; Lawrence Y Agodoa
Journal: Arch Intern Med Date: 2008-04-28

9. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study.

Authors: J C Peterson; S Adler; J M Burkart; T Greene; L A Hebert; L G Hunsicker; A J King; S Klahr; S G Massry; J L Seifter
Journal: Ann Intern Med Date: 1995-11-15 Impact factor: 25.391

10. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

Authors: L Hansson; A Zanchetti; S G Carruthers; B Dahlöf; D Elmfeldt; S Julius; J Ménard; K H Rahn; H Wedel; S Westerling
Journal: Lancet Date: 1998-06-13 Impact factor: 79.321

7 in total

1. Hypertension: New treatment target for systolic blood pressure?

Authors: Richard J Johnson; Laura G Sánchez-Lozada; Bernardo Rodríguez-Iturbe
Journal: Nat Rev Nephrol Date: 2009-12 Impact factor: 28.314

Review 2. Recognition, pathogenesis, and treatment of different stages of nephropathy in patients with type 2 diabetes mellitus.

Authors: George L Bakris
Journal: Mayo Clin Proc Date: 2011-05 Impact factor: 7.616

3. Blood pressure targets for patients with diabetes or kidney disease.

Authors: Colleen Flynn; George L Bakris
Journal: Curr Hypertens Rep Date: 2011-12 Impact factor: 5.369

4. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease.

Authors: Rhonda M Cooper-DeHoff; Yan Gong; Eileen M Handberg; Anthony A Bavry; Scott J Denardo; George L Bakris; Carl J Pepine
Journal: JAMA Date: 2010-07-07 Impact factor: 56.272